+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

CD137 Agonist Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

CD137 Agonist Antibody - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CCR Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
CD (Cluster of Differentiation) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD (Cluster of Differentiation) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
CCR1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CD40 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

CD40 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
HIF-1 Alpha Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

HIF-1 Alpha Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CD 19 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD 19 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CCR4 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR4 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Prolactin Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Prolactin Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
TGF-Beta-1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

TGF-Beta-1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CCR2 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR2 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Notch Signaling Pathway Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Notch Signaling Pathway Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
CD152 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD152 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CCR3 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR3 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Beta-2 Receptors Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-2 Receptors Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CCR5 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR5 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Eg5 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Eg5 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more